{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:45:06Z","timestamp":1792154706794,"version":"4.4.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["141968"],"award-info":[{"award-number":["141968"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP- 142493"],"award-info":[{"award-number":["MOP- 142493"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.psychres.2018.06.070","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T02:11:31Z","timestamp":1531102291000},"page":"114-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"special_numbering":"C","title":["The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review"],"prefix":"10.1016","volume":"268","author":[{"given":"Parita","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Plitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1575-2606","authenticated-orcid":false,"given":"Eric E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Caravaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0379-1333","authenticated-orcid":false,"given":"Julia","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Remington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Gerretsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Graff-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.psychres.2018.06.070_bib0001","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4088\/JCP.09m05785yel","article-title":"An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis","volume":"72","author":"Agid","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2018.06.070_bib0002","unstructured":"American Psychiatric Association, 2000. Diagnostic and statistical manual of mental disorders."},{"issue":"1","key":"10.1016\/j.psychres.2018.06.070_bib0003","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/acps.12742","article-title":"International trends in clozapine use: a study in 17 countries","volume":"136","author":"Bachmann","year":"2017","journal-title":"Acta Psychiatrica Scand."},{"issue":"2","key":"10.1016\/j.psychres.2018.06.070_bib0004","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1176\/ajp.156.2.294","article-title":"Clozapine and risperidone in chronic schizophrenia: effects on symptoms, Parkinsonian side effects, and neuroendocrine response","volume":"156","author":"Breier","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2018.06.070_bib0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5455\/bcp.20141223052008","article-title":"Clozaphobia: fear of prescribers of clozapine for treatment of schizophrenia","volume":"24","author":"Cetin","year":"2014","journal-title":"Bull. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2018.06.070_bib0006","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1176\/appi.ajp.158.4.518","article-title":"Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials","volume":"158","author":"Chakos","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2018.06.070_bib0007","article-title":"Treatment-resistant schizophrenia: prevalence and risk factors","author":"Dammak","year":"2013","journal-title":"Intech"},{"issue":"5","key":"10.1016\/j.psychres.2018.06.070_bib0008","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/pcn.12380","article-title":"Reduced duration of untreated illness over time in patients with schizophrenia spectrum, mood and anxiety disorders","volume":"70","author":"Dell'Osso","year":"2016","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"11","key":"10.1016\/j.psychres.2018.06.070_bib0009","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1017\/S0033291717000435","article-title":"Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors","volume":"47","author":"Demjaha","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2018.06.070_bib0010","article-title":"Discovering Statistics Using SPSS","author":"Field","year":"2005"},{"issue":"1","key":"10.1016\/j.psychres.2018.06.070_bib0011","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1751-7893.2009.00155.x","article-title":"Stigma and treatment delay in first-episode psychosis: a grounded theory study","volume":"4","author":"Franz","year":"2010","journal-title":"Early Interv. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2018.06.070_bib0012","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/wps.20446","article-title":"Improving outcomes of first-episode psychosis: an overview","volume":"16","author":"Fusar-Poli","year":"2017","journal-title":"World Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2018.06.070_bib0013","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1517\/14740338.7.5.525","article-title":"The safety of clozapine in the elderly","volume":"7","author":"Gareri","year":"2008","journal-title":"Expert Opin. Drug Saf."},{"issue":"1","key":"10.1016\/j.psychres.2018.06.070_bib0014","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/acps.12193","article-title":"Practitioner attitudes to clozapine initiation","volume":"130","author":"Gee","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.psychres.2018.06.070_bib0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/2045125316677027","article-title":"Effects of a smoking ban on clozapine plasma concentrations in a nonsecure psychiatric unit","volume":"7","author":"Gee","year":"2017","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.psychres.2018.06.070_bib0016","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/gps.4154","article-title":"The effects of aging on insight into illness in schizophrenia: a review","volume":"29","author":"Gerretsen","year":"2014","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2018.06.070_bib0017","first-page":"1","article-title":"Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? A systematic review","volume":"17","author":"Gillespie","year":"2017","journal-title":"BMC Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2018.06.070_bib0018","article-title":"Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia","volume":"18","author":"Goldstein","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2018.06.070_bib0019","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.psychres.2014.12.046","article-title":"Delay in initiation of clozapine: a retrospective study from a tertiary care hospital in North India","volume":"226","author":"Grover","year":"2015","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.psychres.2018.06.070_bib0020","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s11096-010-9398-5","article-title":"Patterns of clozapine prescribing in a mental health service in New Zealand","volume":"32","author":"Harrison","year":"2010","journal-title":"Pharm. World Sci."},{"issue":"3","key":"10.1016\/j.psychres.2018.06.070_bib0021","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: treatment response and resistance in psychosis (trrip) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2018.06.070_bib0022","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1192\/bjp.bp.111.105833","article-title":"Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation","volume":"201","author":"Howes","year":"2012","journal-title":"Br. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2018.06.070_bib0023","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/YIC.0b013e32836508e6","article-title":"The social and economic burden of treatment-resistant schizophrenia: a systematic literature review","volume":"29","author":"Kennedy","year":"2014","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2018.06.070_bib0024","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1192\/apt.11.2.101","article-title":"Management of clozapine-resistant schizophrenia","volume":"11","author":"Kerwin","year":"2005","journal-title":"Adv. Psychiatr. Treat."},{"issue":"15","key":"10.1016\/j.psychres.2018.06.070_bib0025","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1017\/S0033291716002014","article-title":"Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses","volume":"46","author":"Lally","year":"2016","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.psychres.2018.06.070_bib0026","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/schbul\/sbj067","article-title":"Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia","volume":"32","author":"Lewis","year":"2006","journal-title":"Schizophr. Bull."},{"issue":"17","key":"10.1016\/j.psychres.2018.06.070_bib0027","first-page":"1","article-title":"Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment","volume":"10","author":"Lewis","year":"2006","journal-title":"Health Technol. Assess. (Winchester, England)"},{"issue":"11","key":"10.1016\/j.psychres.2018.06.070_bib0028","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ps.201100435","article-title":"Factors associated with initiation on clozapine and on other antipsychotics among medicaid enrollees","volume":"63","author":"Manuel","year":"2012","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psychres.2018.06.070_bib0029","first-page":"135","article-title":"Pharmacotherapy for treatment-resistant schizophrenia","volume":"7","author":"McIlwain","year":"2011","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.psychres.2018.06.070_bib0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpsyc.60.1.82","article-title":"Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT)","volume":"60","author":"Meltzer","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2018.06.070_bib0031","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4088\/JCP.v69n0214","article-title":"A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia","volume":"69","author":"Meltzer","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2018.06.070_bib0032","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/mp.2012.47","article-title":"Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents","volume":"17","author":"Miyamoto","year":"2012","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2018.06.070_bib0033","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41398-017-0041-2","article-title":"Elevated peripheral expression of neuregulin-1 (NRG1) mRNA isoforms in clozapine-treated schizophrenia patients","volume":"7","author":"Mostaid","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psychres.2018.06.070_bib0034","article-title":"Duration of untreated illness as a key to early intervention in schizophrenia: a review","author":"Murru","year":"2016","journal-title":"Neurosci. Lett"},{"issue":"Suppl 12","key":"10.1016\/j.psychres.2018.06.070_bib0035","first-page":"35","article-title":"Optimizing clozapine treatment","volume":"60","author":"Naber","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl 2","key":"10.1016\/j.psychres.2018.06.070_bib0036","first-page":"S165","article-title":"Antipsychotic prescribing before clozapine in a community psychiatric hospital: a case note review","volume":"25","author":"Najim","year":"2013","journal-title":"Psychiatr. Danub."},{"issue":"1-3","key":"10.1016\/j.psychres.2018.06.070_bib0037","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.schres.2015.01.043","article-title":"Neuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophrenia","volume":"164","author":"Nakajima","year":"2015","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.psychres.2018.06.070_bib0038","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pscychresns.2011.09.006","article-title":"Reduced white matter fractional anisotropy and clinical symptoms in schizophrenia: a voxel-based diffusion tensor imaging study","volume":"202","author":"Nakamura","year":"2012","journal-title":"Psychiatry Res."},{"issue":"7","key":"10.1016\/j.psychres.2018.06.070_bib0039","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1177\/0269881108100320","article-title":"Psychiatrists' attitude towards and knowledge of clozapine treatment","volume":"24","author":"Nielsen","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2018.06.070_bib0040","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"issue":"2","key":"10.1016\/j.psychres.2018.06.070_bib0041","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1192\/bjp.bp.113.127753","article-title":"Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis","volume":"205","author":"Penttila","year":"2014","journal-title":"Br. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2018.06.070_bib0042","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1176\/appi.ajp.162.10.1785","article-title":"Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis","volume":"162","author":"Perkins","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2018.06.070_bib0043","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.euroneuro.2014.07.015","article-title":"Glutamate-mediated excitotoxicity in schizophrenia: a review","volume":"24","author":"Plitman","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2018.06.070_bib0044","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S1041610214001756","article-title":"Effectiveness and safety of clozapine in elderly patients with chronic resistant schizophrenia","volume":"27","author":"Pridan","year":"2015","journal-title":"Int. Psychogeriatr."},{"issue":"4","key":"10.1016\/j.psychres.2018.06.070_bib0045","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/oxfordjournals.schbul.a033412","article-title":"How long to wait for a response to clozapine: a comparison of time course of response to clozapine and conventional antipsychotic medication in refractory schizophrenia","volume":"25","author":"Rosenheck","year":"1999","journal-title":"Schizophren. Bull"},{"issue":"5","key":"10.1016\/j.psychres.2018.06.070_bib0046","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","volume":"209","author":"Siskind","year":"2016","journal-title":"Br. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2018.06.070_bib0047","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/schbul\/sbr004","article-title":"Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review","volume":"38","author":"Sommer","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.psychres.2018.06.070_bib0048","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1176\/appi.ajp.2015.15030332","article-title":"Comparative effectiveness of clozapine and standard antipsychotic treatment in adults with schizophrenia","volume":"173","author":"Stroup","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"1-3","key":"10.1016\/j.psychres.2018.06.070_bib0049","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.schres.2011.09.016","article-title":"Treatment resistant schizophrenia and response to antipsychotics: a review","volume":"133","author":"Suzuki","year":"2011","journal-title":"Schizophr. Res."},{"issue":"1-2","key":"10.1016\/j.psychres.2018.06.070_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2012.02.013","article-title":"Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation","volume":"197","author":"Suzuki","year":"2012","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.psychres.2018.06.070_bib0051","first-page":"32","article-title":"Factors associated with response to clozapine in schizophrenia: a review","volume":"44","author":"Suzuki","year":"2011","journal-title":"Psychopharmacol. Bull."},{"issue":"1","key":"10.1016\/j.psychres.2018.06.070_bib0052","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4088\/JCP.v64n0107","article-title":"Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review","volume":"64","author":"Taylor","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2018.06.070_bib0053","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0006-3223(98)00093-6","article-title":"A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia","volume":"43","author":"Tollefson","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2018.06.070_bib0054","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/YIC.0000000000000086","article-title":"Delayed initiation of clozapine may be related to poor response in treatment-resistant schizophrenia","volume":"30","author":"Ucok","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2018.06.070_bib0055","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/PPA.S124658","article-title":"Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness","volume":"11","author":"Velligan","year":"2017","journal-title":"Patient Preference Adherence"},{"key":"10.1016\/j.psychres.2018.06.070_bib0056","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sby015.215","article-title":"Clozapine and long-term mortality risk in patients with schizophrenia: a systematic review and meta-analysis of studies lasting 1.1-12.5 Years","author":"Vermeulen","year":"2018","journal-title":"Schizophr. Bull"},{"issue":"1-2","key":"10.1016\/j.psychres.2018.06.070_bib0057","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.schres.2015.07.045","article-title":"Correlation between delay in initiating clozapine and symptomatic improvement","volume":"168","author":"Yada","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2018.06.070_bib0058","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.psychres.2017.01.064","article-title":"The critical treatment window of clozapine in treatment-resistant schizophrenia: secondary analysis of an observational study","volume":"250","author":"Yoshimura","year":"2017","journal-title":"Psychiatry Res."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517811830564X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517811830564X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:28:57Z","timestamp":1759037337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016517811830564X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":58,"alternative-id":["S016517811830564X"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2018.06.070","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2018.06.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}